Nurse practitioner-delivered cognitive-behavioral treatment as a novel implementation route for irritable bowel syndrome: A proof of concept

被引:0
|
作者
Murray, Helen Burton [1 ,2 ,3 ,6 ]
Weeks, Imani [3 ]
Thurler, Andrea [3 ]
Calabrese, Samantha [3 ]
Lapinel, Mary Kate [3 ]
Madva, Elizabeth N. [1 ,2 ]
Staller, Kyle [2 ,3 ,4 ]
Keefer, Laurie [5 ]
Kuo, Braden [2 ,3 ,4 ]
机构
[1] Harvard Med Sch, Dept Psychiat, Boston, MA USA
[2] Massachusetts Gen Hosp, Ctr Neurointestinal Hlth, Boston, MA USA
[3] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA USA
[4] Harvard Med Sch, Dept Med, Boston, MA USA
[5] Icahn Sch Med Mt Sinai, New York, NY USA
[6] Massachusetts Gen Hosp, Div Gastroenterol, 55 Fruit St,Bartlett 9, Boston, MA 02114 USA
来源
NEUROGASTROENTEROLOGY AND MOTILITY | 2023年 / 35卷 / 04期
关键词
cognitive-behavioral therapy; disorders of gut-brain interaction; functional gastrointestinal disorders; irritable bowel syndrome; nurse practitioners; nurses; EXPOSURE-BASED TREATMENT; VISCERAL SENSITIVITY; STRESS-MANAGEMENT; THERAPY; ANXIETY; CARE; VALIDATION; DEPRESSION; PAIN; SYMPTOMS;
D O I
10.1111/nmo.14526
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundExposure-based cognitive-behavioral therapy (exposure-CBT) is efficacious for irritable bowel syndrome (IBS). However, few patients receive exposure-CBT due to a lack of behavioral health providers trained in brain-gut behavior therapies. Nurse practitioners (NPs) could fill a critical need for scalable delivery methods. In a pragmatic investigation of a 5-session NP-delivered exposure-CBT for adults with Rome IV-defined IBS, we evaluated treatment feasibility and acceptability and explored changes clinical outcomes. MethodsExposure-CBT was delivered as part of routine care involving four sessions every other week and a 2-month booster session. Patients could electively participate in an observational study including pre-, mid-, and post-treatment surveys and a post-treatment qualitative interview. Independently coded ratings of NP treatment protocol adherence and competence ratings were completed from audio recordings, rated on a 1 (not at all) to 5 (completely) scale. ResultsTwenty-five patients consented (ages 22-67 years; 76% female; 48% IBS-diarrhea predominant). There was high feasibility-adherence average = 4.1, NP competence average = 4.8, 72% treatment completion, 93% satisfaction scores >= 3. Treatment satisfaction was high (rated as 4/4 "very satisfied" by n = 9 and as 3/4 "mostly satisfied" by n = 5). There were improvements in clinical outcomes across treatment with large effects for IBS-symptom severity (-53%; Hedge's g = 1.0; 95% confidence interval [CI] = 0.5, 1.5) and IBS quality of life (+31%; Hedge's g = 0.8; 95% CI = 0.4, 1.2). ConclusionsNP-delivered exposure-CBT for IBS was initially feasible and acceptable with promising clinical improvements. Findings will inform a future NIH Stage 1B/ORBIT Phase IIB pilot randomized control trial.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Cognitive-behavioral group therapy for irritable bowel syndrome: Effects and long-term follow-up
    vanDulmen, AM
    Fennis, JFM
    Bleijenberg, G
    PSYCHOSOMATIC MEDICINE, 1996, 58 (05): : 508 - 514
  • [42] Comprehensive Cognitive-Behavioral Interventions Augment Diaphragmatic Breathing for Rumination Syndrome: A Proof-of-Concept Trial
    Murray, Helen Burton
    Zhang, Fengqing
    Call, Christine C.
    Keshishian, Ani
    Hunt, Rowan A.
    Juarascio, Adrienne S.
    Thomas, Jennifer J.
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (10) : 3461 - 3469
  • [43] Comprehensive Cognitive-Behavioral Interventions Augment Diaphragmatic Breathing for Rumination Syndrome: A Proof-of-Concept Trial
    Helen Burton Murray
    Fengqing Zhang
    Christine C. Call
    Ani Keshishian
    Rowan A. Hunt
    Adrienne S. Juarascio
    Jennifer J. Thomas
    Digestive Diseases and Sciences, 2021, 66 : 3461 - 3469
  • [44] Internet-Delivered Cognitive Behavioral Therapy in Patients With Irritable Bowel Syndrome: Systematic Review and Meta-Analysis
    Kim, Hyunjung
    Oh, Younjae
    Chang, Sun Ju
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2022, 24 (06)
  • [45] Group Cognitive-Behavioral Therapy With Interoceptive Exposure for Drug-Refractory Irritable Bowel Syndrome: A Randomized Controlled Trial
    Kikuchi, Shino
    Oe, Yuki
    Ito, Yuri
    Sozu, Takashi
    Sasaki, Yohei
    Sakata, Masatsugu
    Luo, Yan
    Sahker, Ethan
    Horikoshi, Masaru
    Seno, Hiroshi
    Furukawa, Toshi A.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (04): : 668 - 677
  • [46] Comparison of the Effectiveness of Hypnotherapy and Cognitive-Behavioral Therapy on Chronic Pain Indices and Cognitive-Emotional Regulation in Patients with Irritable Bowel Syndrome
    Pourkaveh, Atefeh
    Pirani, Zabih
    Pourasghar, Mehdi
    Sadeghi, Anahita
    Poustchi, Hossein
    IRANIAN JOURNAL OF PSYCHIATRY AND BEHAVIORAL SCIENCES, 2023, 17 (01)
  • [47] A mixed methods feasibility study to evaluate the use of a low-intensity, nurse-delivered cognitive behavioural therapy for the treatment of irritable bowel syndrome
    Dainty, Andrew David
    Fox, Mark
    Lewis, Nina
    Hunt, Melissa
    Holtham, Elizabeth
    Timmons, Stephen
    Kinsella, Philip
    Wragg, Andrew
    Callaghan, Patrick
    BMJ OPEN, 2014, 4 (06):
  • [48] MODIFIED COGNITIVE BEHAVIORAL TREATMENT FOR IRRITABLE BOWEL SYNDROME IN A PRIMARY CARE SETTING: A CLINICAL CASE EXAMPLE
    Nicasio, Andel V.
    Blaney, Cerissa L.
    Cannarozzi, Maria L.
    ANNALS OF BEHAVIORAL MEDICINE, 2019, 53 : S772 - S772
  • [49] PREDICTORS OF RESPONSE TO INTEROCEPTIVE EXPOSURE-BASED COGNITIVE-BEHAVIORAL THERAPY (CBT-IE) IN IRRITABLE BOWEL SYNDROME PATIENTS IN JAPAN
    Funaba, Misako
    Kawanishi, Hitomi
    Fujii, Yasushi
    Higami, Koyo
    Tomita, Yoshitoshi
    Sekiguchi, Atsushi
    Ando, Tetsuya
    PSYCHOSOMATIC MEDICINE, 2020, 82 (06): : A89 - A89
  • [50] OUTCOMES OF AN UNGUIDED, WEB-BASED COGNITIVE BEHAVIORAL THERAPY PROGRAM FOR IRRITABLE BOWEL SYNDROME DELIVERED DURING THE COVID-19 PANDEMIC
    Owusu, Jocelynn T.
    Sibelli, Alice
    Sipe, Walter E.
    Oser, Megan
    GASTROENTEROLOGY, 2021, 160 (06) : S677 - S677